ReBio Technologies is a biomedical company that specializes in drug release technologies. Its polymer gel-based platform SISU helps to support the release profile and duration of long-acting injectable small molecule and biomolecule drugs. The company develops tools to design new biosynthetic pathways in a range of microbial hosts to promote the production of high-value chemicals through fermentation.